LPL Financial’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-6,261
| Closed | -$803K | – | 5828 |
|
|
2025
Q2 | $803K | Sell |
6,261
-9,944
| -61% | -$1.03M | ﹤0.01% | 3946 |
|
|
2025
Q1 | $1.43M | Buy |
16,205
+8,248
| +104% | +$805K | ﹤0.01% | 3246 |
|
|
2024
Q4 | $694K | Sell |
7,957
-1,124
| -12% | -$103K | ﹤0.01% | 3807 |
|
|
2024
Q3 | $840K | Sell |
9,081
-152
| -2% | -$15.1K | ﹤0.01% | 3551 |
|
|
2024
Q2 | $995K | Sell |
9,233
-353
| -4% | -$35.3K | ﹤0.01% | 3262 |
|
|
2024
Q1 | $909K | Buy |
9,586
+216
| +2% | +$18.5K | ﹤0.01% | 3272 |
|
|
2023
Q4 | $864K | Sell |
9,370
-1,424
| -13% | -$92.3K | ﹤0.01% | 3164 |
|
|
2023
Q3 | $542K | Sell |
10,794
-142
| -1% | -$7.59K | ﹤0.01% | 3423 |
|
|
2023
Q2 | $691K | Buy |
10,936
+256
| +2% | +$13.9K | ﹤0.01% | 3168 |
|
|
2023
Q1 | $480K | Buy |
10,680
+2,124
| +25% | +$95.7K | ﹤0.01% | 3369 |
|
|
2022
Q4 | $375K | Buy |
8,556
+3,810
| +80% | +$183K | ﹤0.01% | 3494 |
|
|
2022
Q3 | $313K | Buy |
+4,746
| New | +$305K | ﹤0.01% | 3541 |
|
|
2022
Q1 | – | Sell |
-2,347
| Closed | -$251K | – | 4206 |
|
|
2021
Q4 | $251K | Buy |
2,347
+19
| +0.8% | +$1.99K | ﹤0.01% | 3820 |
|
|
2021
Q3 | $239K | Buy |
+2,328
| New | +$217K | ﹤0.01% | 3824 |
|
|
2021
Q2 | – | Sell |
-18,809
| Closed | -$1.83M | – | 4231 |
|
|
2021
Q1 | $1.83M | Buy |
18,809
+16,006
| +571% | +$1.6M | ﹤0.01% | 1908 |
|
|
2020
Q4 | $314K | Sell |
2,803
-581
| -17% | -$61.2K | ﹤0.01% | 3161 |
|
|
2020
Q3 | $314K | Buy |
3,384
+456
| +16% | +$35.1K | ﹤0.01% | 2875 |
|
|
2020
Q2 | $228K | Buy |
+2,928
| New | +$198K | ﹤0.01% | 3038 |
|
|
2020
Q1 | – | Sell |
-3,428
| Closed | -$275K | – | 3238 |
|
|
2019
Q4 | $275K | Buy |
3,428
+221
| +7% | +$16.5K | ﹤0.01% | 2851 |
|
|
2019
Q3 | $236K | Sell |
3,207
-6,603
| -67% | -$571K | ﹤0.01% | 2867 |
|
|
2019
Q2 | $925K | Buy |
9,810
+5,980
| +156% | +$494K | ﹤0.01% | 1778 |
|
|
2019
Q1 | $307K | Buy |
+3,830
| New | +$283K | ﹤0.01% | 2611 |
|
|
2018
Q4 | – | Sell |
-5,262
| Closed | -$411K | – | 3087 |
|
|
2018
Q3 | $411K | Buy |
+5,262
| New | +$366K | ﹤0.01% | 2400 |
|
Other funds holding BPMC
IA
HNB
LPL Financial's BPMC Position: Q3 2025 in Review
LPL Financial sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 6,261 shares — an estimated $803K sold.
LPL Financial first reported a position in BPMC in Q3 2018 and held it in 23 quarters. The position peaked at $1.83M in Q1 2021. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- LPL Financial reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- LPL Financial sold 6,261 Blueprint Medicines shares in Q3 2025, an estimated $803K.
- LPL Financial first reported a position in Blueprint Medicines in Q3 2018 and held it in 23 quarters.
- LPL Financial's Blueprint Medicines position peaked at $1.83M in Q1 2021.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on LPL Financial's 13F filing for Q3 2025, filed 12 Nov 2025.